(Q44348964)

2 December 2017

title

Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid (English)

1 reference

2 December 2017

1 reference

pemphigus vulgaris

1 reference

Gustavo Mazzi

1

1 reference

2 December 2017

Antonino Raineri

2

1 reference

2 December 2017

Francesco Angelo Zanolli

3

1 reference

2 December 2017

Claudio Da Ponte

4

1 reference

2 December 2017

Dina De Roia

5

1 reference

2 December 2017

Liliana Santarossa

6

1 reference

2 December 2017

Renato Guerra

7

1 reference

2 December 2017

Bianca Maria Orazi

8

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Transfusion and Apheresis Science

2 December 2017

published in

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

13-18

1 reference

Pemphigus and bullous pemphigoid

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Pemphigus--diseases of antidesmosomal autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Correlation of pemphigoid and pemphigus antibody titres with activity of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Therapy of pemphigus vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Effects of cyclosporin on bullous pemphigoid and pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Mycophenolate is effective in the treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Bullous pemphigoid treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Plasma exchange in the treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Plasmapheresis as a steroid saving procedure in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

Pathophysiology and therapy of pemphigus in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900095-2

7 January 2021

10.1016/S1473-0502(02)00095-2

Identifiers

DOI

1 reference

2 December 2017

1 reference